Summary

Geneza Pharmaceuticals GP Phenyl 100 is presented in a 10-milliliter multidose vial, labeled to contain 100 milligrams of nandrolone phenylpropionate per milliliter. To ensure product quality and verify label claims, samples were independently procured and funded for analysis by AnabolicLab. These samples were purchased from a European-based internet source between August 1, 2016, and September 15, 2016, and submitted to SIMEC AG, an internationally accredited analytical laboratory, for comprehensive testing.

The analysis included HPLC-UV quantitative dosage testing and microbiological evaluations (TAMC and TYMC). The product exceeded its label claim, with a measured content of 111.3 mg/ml nandrolone phenylpropionate, which is 11.3% above the labeled dosage. No microbiological contamination was detected.

Testing Results and Authentication

The samples were received by SIMEC AG on September 29, 2016, and the report was finalized on November 17, 2016. The product was identified with a lot number GP137CN, an expiration date of February 2018, and an ISN number L8T4921U79DP, which was successfully verified on genezapharmaceuticals.com.

Product Overview

• Manufacturer: Geneza Pharmaceuticals
• Product Name: GP Phenyl 100
• Active Ingredient: Nandrolone Phenylpropionate
• Lot Number: GP137CN
• ISN Number: L8T4921U79DP
• Expiration Date: February 2018
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 100 mg/ml nandrolone phenylpropionate

Sample Acquisition and Testing

• Date Purchased: Between August 1, 2016, and September 15, 2016
• Source: European-based internet supplier
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: September 29, 2016
• Date Report Completed: November 17, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 100 mg/ml nandrolone phenylpropionate
• Measured Dosage: 111.3 mg/ml nandrolone phenylpropionate
• Accuracy: 111.3% of the labeled claim
• Variance: +11.3% (measured dosage above the label claim by 11.3%)

Microbiological Contamination Testing:

• TAMC: No contamination detected
• TYMC: No contamination detected

Report Number: #GP-NPP-10172016

Conclusion

The analysis of Geneza Pharmaceuticals GP Phenyl 100 revealed that the product exceeded its labeled claim, with a measured concentration of 111.3 mg/ml nandrolone phenylpropionate, reflecting an 11.3% overdose. No microbiological contamination was detected, confirming the product’s safety in terms of sterility. These findings suggest strong manufacturing accuracy with minimal safety concerns.

AnabolicLab’s independent analysis underscores the importance of transparency and provides valuable information for consumers to make informed decisions.

Commitment to Harm Reduction

AnabolicLab is dedicated to promoting harm reduction through independent testing and transparent reporting. By funding and publishing analyses, AnabolicLab supports accountability within the anabolic steroid market, enabling consumers to access reliable product information.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Geneza Pharmaceuticals GP Phenyl 100 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Geneza Pharma GP Phenyl 100 Dosage Quantification Lab Results [PDF]
How many milligrams of nandrolone phenylpropionate are in each milliliter of Geneza Pharma GP Phenyl 100? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (November 17, 2016) …

Size	2.51 MB
Downloaded	785 times
Last Updated	November 19, 2016
Download

---